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Neil Moreton McKern, the first author on
the landmark paper describing the crystal
structure of the human insulin receptor
ectodomain (1), passed away on the 20
March 2014 after a year-long battle with
multiple myeloma.
Neil McKern was born on 17 December
1946 at Richmond, New South Wales. His
career in science began at the age of 18 as a
technical assistant to Dr. Fred Stewart in the
CSIRO Division of Protein Chemistry in
Parkville, VIC, Australia, where he worked
on the chemical synthesis of the peptide
hormone oxytocin. Neil then studied part
time, obtaining a B.Sc. degree in 1971 and
a Ph.D. degree in 1981, both from the Uni-
versity of Melbourne. His thesis title was
“Serum somatomedin and the regulation of
growth-studies with rodent models.”
Over the subsequent 10 years at CSIRO,
Neil contributed to several aspects of pro-
tein science, including the purification of
wool proteins for structure determination,
the sequencing of the pilin protein of Dich-
elobacter nodosus (which causes footrot in
sheep), the study of the proteins of infec-
tious bursal disease virus (a major poultry
pathogen) coupled with development of a
recombinant vaccine, and the study of vari-
ation in the coat protein sequence across
the Potyviridae (the largest family of plant
viruses). These projects reflected the agri-
cultural priorities of CSIRO’s science at
the time.
These endeavors laid the foundation for
Neil’s involvement starting in 1992 with
what was to become a “grand challenge”
at CSIRO, namely, Colin Ward’s program
to understand the structural biology of the
insulin receptor, the Type 1 insulin-like
growth factor, and the epidermal growth
factor receptor. Spurred on by the suc-
cessful determination of the structure of
the human growth hormone bound to its
receptor by Tony Kosiakoff and colleagues
at Genentech, the allure of a structure of
insulin bound to its receptor was irre-
sistible. However, the complexity of these
receptor ectodomains proved to be sub-
stantial – high levels of glycosylation, high
numbers of disulfide bonds, and the exis-
tence of multiple liganded states. Neil
masterminded the practicalities of puri-
fying bulk quantities of the ectodomains
and truncated ectodomain fragments of
these receptors from large (100 l plus) scale
mammalian cell culture supernatants. His
demands were high – to achieve tens of
milligram quantities of receptor protein
displaying no more than one band on an
isoelectric focusing gel. He set up the first
forays of the lab into robotic protein crys-
tallization and the combination of this
technology with isoelectrically pure pro-
tein finally delivered the first – and still
only – structures of the Type 1 IGF-1 recep-
tor L1-CR-L2 fragment (2), the insulin
receptor L1-CR-L2 fragment (3), and the
FIGURE 1 | Neil McKern in 2006.
intact insulin receptor ectodomain (1).
Such care and ingenuity absorbed Neil until
2007, at which point CSIRO terminated
the project upon Colin’s retirement. His
endeavors also led to structures of the trun-
cated ectodomains of the epidermal growth
factor receptor in complex with TGFα (4)
and of its co-family member ErbB2 (5).
Neil retired from CSIRO in 2010, but not
before playing a key role in ensuring that
the structural studies of the insulin recep-
tor continued at the neighboring Walter
and Eliza Hall Institute of Medical Research
in Melbourne.
Always striking to all Neil’s colleagues
was his cheerful optimism, which was cou-
pled with healthy cynicism about the way
in which his employing organization func-
tioned. Part of this optimism derived no
doubt from his passion for running, which
seemed to not only energize his body but
also to provide a wealth of ideas about how
to prepare the next sample for crystalliza-
tion. Giving up on the “grand challenge”
would have to Neil been akin to pulling out
of a marathon half way along the course.
Neil was dedicated to his family, which
together faced the challenge of re-building
their beloved family retreat in Marysville
after it burnt to the ground in the devastat-
ing Black Saturday bushfires of 2009.
For us, and for the many others who
worked with him, his enthusiasm for sci-
ence, and his collegial support is greatly
missed.
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